The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to saving lives and reducing the burden of disease in low-and middle-income countries, while strengthening the capabilities of governments and the private sector in those countries to create and sustain high-quality health systems that can succeed without our assistance. For more information, please visit: http://www.clintonhealthaccess.org
Immunization is one of the most successful public health interventions in history. National immunization programs reach >100 million infants every year and have averted globally two to three million deaths every year since the launch of the Expanded Program for Immunization (EPI) in 1974, whilst the pneumococcal conjugate vaccine (PCV) and rotavirus vaccines could save ~1 million lives per year. Furthermore, great advances in discovering and financing new vaccines provides a great opportunity for countries to further reduce burden of disease such as human papillomavirus (HPV). Despite these successes, 1.5 million children still die each year of vaccine-preventable diseases, many of them in low-income countries, as immunization programs there face unprecedented challenges.
Since 2010, the Clinton Health Access Initiative (CHAI) has worked to save lives and reduce the burden from vaccine preventable diseases by improving access to immunization services in resource-limited setting by strengthening national immunization programs and by leveraging its experience in-country to improve the global immunization ecosystem. CHAI is pursuing six complementary strategic goals:
CHAI's vaccine program very closely supports the national immunization programs in 13 focus countries - Cameroon, Ethiopia, India, Indonesia, Kenya, Lao PDR, Lesotho, Nigeria, Papua New Guinea, Sierra Leone, Tanzania, Uganda and Vietnam- and also engages with global stakeholders such as Gavi, WHO and UNICEF to inform global policies and practices.
New Vaccine Introduction and Covid-19 vaccine
On March 11, 2020, the World Health Organization (WHO) declared COVID-19, a global pandemic. The global pandemic has caused major challenges to health and economic indicators globally as Governments have worked to control the spread of COVID-19 and prevent further outbreaks. In the rush to mitigate the effects of the pandemic, global partners and pharmaceutical already launched 150+ vaccines into development. Typically, vaccines take 7-15+ years for development, but the global efforts are potentially propelling us towards safe, efficacious vaccine ready for production as fast as 10 months after the start of the global pandemic with production scaling up shortly thereafter.
Analogously, global partners and countries will have to accelerated vaccine introduction processes from 12-18+ months to ~6 months to ensure readiness for this vaccine. Moreover, due to development, manufacturing, access, application and financing terms being developed in parallel countries need to take decisions with significantly more limited information than usual to commence planning. The vaccine will likely also have additional challenges relative to an infant vaccine introduction as it faces 1) novel storage and delivery mechanisms, 2) a target cohort that is not typically targeted with vaccination, and 3) more public scrutiny and concern as timelines are condensed. Thus, countries will need to have both robust decision-making processes, delivery strategies, and rollout plans to account for the new challenges.
CHAI is currently in the position to support the novel considerations and build off of significant experience of both infant vaccine and new complex vaccine decision-making and introduction to target successful COVID-19 new vaccine processes in our focal countries. CHAI is also currently coordinating with key global partners to support lessons sharing and guidance development to accelerate COVID-19 vaccine introductions globally.
We are seeking an Associate to join the Global Vaccines Delivery team and support CHAI's work in improving coverage and equity through new vaccine introductions and enhancing service delivery across focus countries, particularly as it relates to the COVID-19 vaccine decision making and introduction process.
We are seeking a motivated and mission-oriented individual with strong analytic, problem-solving, and cross-cultural communication skills. The candidate should be experienced at presenting data and messages powerfully through written documents and presentations; working collaboratively in a fast-paced, multi-cultural environment; and functioning independently with minimal guidance.
Location: This role has flexibility to be based in a CHAI program country, pending country team leadership approval. Base location in a sub-Saharan Africa program country is strongly preferred.
Key responsibilities for this role include, but are not limited to:
1) Provide strategic and programmatic support for the design and implementation of key in-country work on COVID-19 and other new vaccine introductions. The successful candidate will provide both strategic and technical support to the select CHAI focal countries on COVID-19 and other new vaccine introductions. These activities will include collaboration with CHAI country program staff to support select CHAI focal countries on
While the focus of this role is expected to be on COVID-19 vaccination, the successful candidate may also have opportunity and be requested to carry out support to other critical new vaccination work within CHAI’s portfolio or scoping, such as infant and HPV vaccination programs as needed.
2) Support the development of CHAI's vaccines program, in collaboration with program and country leadership
3) Support program and grant management, in collaboration with program and country leadership